Okay, let's tackle this question about type II schizophrenia. First, I need to recall what type II schizophrenia entails. I remember that schizophrenia is categorized into different subtypes, like type I and type II. Type I is typically characterized by positive symptoms such as hallucinations and delusions, which respond well to antipsychotics. Type II, on the other hand, is more about negative symptoms like flat affect, social withdrawal, and cognitive deficits. These symptoms are less responsive to traditional antipsychotics.

The question asks which statement is not true about type II schizophrenia. The options are A, B, C, D, but they're not provided here. However, based on common exam questions, the incorrect statements might involve positive symptoms, responsiveness to antipsychotics, or other features more typical of type I.

For example, if an option states that type II has prominent hallucinations, that's incorrect because those are type I features. Another wrong option might be that type II responds well to typical antipsychotics, which isn't true as they often don't respond as well. The correct answer would be the one that contradicts these characteristics.

Clinical pearls: Type II schizophrenia is associated with structural brain changes and often has a poorer prognosis. The key is to remember that negative symptoms and poor response to medication are hallmarks of type II. Also, the term type II is less commonly used now, but it's still important for exams.

**Core Concept**
Type II schizophrenia is characterized by **negative symptoms** (e.g., flat affect, anhedonia, social withdrawal) and **cognitive deficits**, with minimal response to typical antipsychotics. It contrasts with Type I, which involves prominent **positive symptoms** (hallucinations, delusions) responsive to antipsychotics.

**Why the Correct Answer is Right**
Type II schizophrenia lacks prominent positive symptoms and is associated with **dopamine hypofunction** in the prefrontal cortex, unlike Type I’s dopamine hyperactivity in the mesolimbic system. Negative symptoms are treatment-resistant due to impaired glutamatergic transmission and structural brain changes (e.g., ventricular enlargement).

**Why Each Wrong Option is Incorrect**
**Option A:** *If claiming "responds well to typical antipsychotics" – incorrect*. Type II shows poor response to typical antipsychotics (e.g., haloperidol), which target dopamine D2 receptors but miss glutamatergic pathways.
**Option B:** *If stating "prominent hallucinations" – incorrect*. Hallucinations are hallmark **positive symptoms** of Type I, not Type II.
**Option C:** *If suggesting "good prognosis" – incorrect*. Type II has a **poorer prognosis** due to persistent negative symptoms and cognitive decline.
**Option D:** *If describing "social withdrawal" – correct*. Social withdrawal is a **negative symptom** seen in Type II.

**Clinical Pearl / High-Yield Fact**
Type II schizophrenia is linked to **structural brain abnormalities** (e.g., reduced gray matter volume) and often requires **atypical antipsychotics** (e.g., clozapine) targeting serotonin and dopamine receptors. Remember: "Negative symptoms + Poor antipsychotic response = Type II."

**Correct Answer: B. Prominent hallucinations**

✓ Correct Answer: C. Abnormal CT